VIRIDIAN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.45 USD | -8.07% |
|
-3.24% | -38.25% |
| 09/05 | Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating | MT |
| 09/05 | B. Riley Downgrades Viridian Therapeutics to Neutral From Buy | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -8.07% | -3.24% | -38.25% | -41.29% | -68.20% | 934M |  |  | |
- Stock Market
- Equities
- VRDN Stock
- Charts Viridian Therapeutics, Inc.
- Relative Strength Chart
